CCL11 and Insulin resistance: Additionally, studies have shown that levels of Eotaxin-1 are associated with metabolic disorders such as insulin resistance, impaired glucose tolerance and abnormal lipid metabolism, which are all risk factors for the development of NAFLD (38).